Heike Richly

机构：Essen University Hospital · ORCID：0000-0001-6081-0978

发表论文 84 篇 · 总被引 3377 次 · h-index 25

代表论文

• Regorafenib (BAY 73-4506) in advanced colorectal cancer: a phase I study (2012 · British Journal of Cancer · 被引 254)
• Rogaratinib in patients with advanced cancers selected by FGFR mRNA expression: a phase 1 dose-escalation and dose-expansion study (2019 · The Lancet Oncology · 被引 181)
• A phase I dose-escalation study of IMAB362 (Zolbetuximab) in patients with advanced gastric and gastro-oesophageal junction cancer (2018 · European Journal of Cancer · 被引 171)
• Neutralizing GDF-15 can overcome anti-PD-1 and anti-PD-L1 resistance in solid tumours (2024 · Nature · 被引 125)
• Phase I clinical study of the toll-like receptor 9 agonist MGN1703 in patients with metastatic solid tumours (2014 · European Journal of Cancer · 被引 69)
• A prospective randomised phase-II trial with gemcitabine versus gemcitabine plus sunitinib in advanced pancreatic cancer (2014 · European Journal of Cancer · 被引 63)